Winer, E., Othus, M., Atallah, E., Tsai, S., Sabloff, M., Osman, A., Im, A., Loghavi, S., Moseley, A., Wood, B., Fang, M., Yeung, C., Chen, X., Qu, X., Harris, L., Ghatak, S., Gore, S., Uy, G., Michaelis, L., Odenike, O., Stone, R., Luger, S., Assouline, S., Erba, H., Litzow, M., Lachowiez, C., Reagan, J., Borate, U., Savoie, M. L., Jonas, B., Roy, N., Radich, J., Little, R., Jiwani, S. (2025). Myeloid malignancies molecular analysis for therapy choice (myeloMATCH): Rapid availability of clinical, pathologic and molecular features for treatment assignment in the first 550 patients.. Blood. https://doi.org/10.1182/blood-2025-5279